Systematic echocardiography is not efficacious when screening an ethnically diverse cohort of athletes in West Asia

European Journal of Preventive Cardiology

Volumn 22, Issue 2, 2015, Pages 263-270

  Riding, Nathan R ^a,b   Sharma, Sanjay ^c   Salah, Othman ^a   Khalil, Nelly ^a   Carré, François ^d   George, Keith P ^b   Hamilton, Bruce ^e   Chalabi, Hakim ^a   Whyte, Gregory P ^b   Wilson, Mathew G ^a  

^a ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITÉ DE RENNES 1   (France)

^e Medical Lead HPSNZ National Training Centre Millenium Institute of Sport and Health   (New Zealand)

Author keywords

Cost effectiveness; echocardiography; pre participation screening; sudden cardiac death

Indexed keywords

ARTICLE; ATHLETE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MASS SCREENING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH; WEST ASIAN; WOLFF PARKINSON WHITE SYNDROME; ASIA; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; DEATH, SUDDEN, CARDIAC; ECHOGRAPHY; ECONOMICS; ETHNOLOGY; PROCEDURES; SPORTS MEDICINE;

ASIA; ATHLETES; COHORT STUDIES; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART DEFECTS, CONGENITAL; HUMANS; SPORTS MEDICINE;

EID: 84920992042     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313506549     Document Type: Article

References (33)

1. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007 ; 115: 1643-1455
2. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005 ; 26: 516-524
3. Rawlins J, Bhan A, Sharma S. Left ventricular hypertrophy in athletes. Eur J Echocardiogr. 2009 ; 10: 350-356
4. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol. 2008 ; 51: 1033-1039
5. Wilson MG, Chandra N, Papadakis M, et al. Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities?. J Cardiovasc Magn Reson. 2011 ; 13: 77-77
6. Papadakis M, Wilson MG, Ghani S, et al. Impact of ethnicity upon cardiovascular adaptation in competitive athletes: relevance to preparticipation screening. Br J Sports Med. 2012 ; 46: i22 - i28
7. Kervio G, Pelliccia A, Nagashima J, et al. Alterations in echocardiographic and electrocardiographic features in Japanese professional soccer players: comparison to African-Caucasian ethnicities. Eur J Prev Cardiol. 2013 ; 20 (5). 880-888
8. Wilson MG, Chatard JC, Carre F, et al. Prevalence of electrocardiographic abnormalities in West-Asian and African male athletes. Br J Sports Med. 2012 ; 46: 341-3437
9. Drezner JA. Standardised criteria for ECG interpretation in athletes: a practical tool. Br J Sports Med. 2012 ; 46: i6 - i8
10. Riding NR, Salah O, Sharma S, et al. ECG and morphologic adaptations in Arabic athletes: are the European Society of Cardiology's recommendations for the interpretation of the 12-lead ECG appropriate for this ethnicity?. Br J Sports Med. 2014 ; 48: 1138-1143
11. Richard P, Denjoy I, Fressart V, et al. Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: is sporting disqualification really necessary?. Br J Sports Med. 2012 ; 46: i59 - i68
12. Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010 ; 31: 2715-2726
13. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996 ; 276: 199-204
14. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995 ; 92: 785-789
15. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003 ; 41: 974-980
16. Pelliccia A, Di Paolo FM, Corrado D, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006 ; 27: 2196-2200
17. Stefani L, Galanti G, Toncelli L, et al. Bicuspid aortic valve in competitive athletes. Br J Sports Med. 2008 ; 42: 31-35, discussion 5
18. Rizzo M, Spataro A, Cecchetelli C, et al. Structural cardiac disease diagnosed by echocardiography in asymptomatic young male soccer players: implications for pre-participation screening. Br J Sports Med. 2012 ; 46: 371-373
19. Bellenger NG, Francis JM, Davies CL, et al. Establishment and performance of a magnetic resonance cardiac function clinic. J Cardiovasc Magn Reson. 2000 ; 2: 15-22
20. Bellenger NG, Grothues F, Smith GC, et al. Quantification of right and left ventricular function by cardiovascular magnetic resonance. Herz. 2000 ; 25: 392-399
21. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005 ; 112: 855-861
22. Maron BJ, Lindberg J, Haas TS, et al. Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy. Am J Cardiol. 2010 ; 105: 1643-1644
23. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003 ; 108: 54-59
24. Moon JC, Fisher NG, McKenna WJ, et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004 ; 90: 645-649
25. Popovic ZB, Kwon DH, Mishra M, et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr. 2008 ; 21: 1299-1305
26. Wheeler MT, Heidenreich PA, Froelicher VF, et al. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med. 2010 ; 152: 276-286
27. Hamilton B, Levine BD, Thompson PD, et al. Debate: challenges in sports cardiology; US versus European approaches. Br J Sports Med. 2012 ; 46: i9 - i14
28. Drezner JA, Harmon KG, Borjesson M. Incidence of sudden cardiac death in athletes: where did the science go?. Br J Sports Med. 2011 ; 45: 947-948
29. Harmon KG, Asif IM, Klossner D, et al. Incidence of sudden cardiac death in national collegiate athletic association athletes. Circulation. 2011 ; 123: 1594-1600
30. de Noronha SV, Sharma S, Papadakis M, et al. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study. Heart. 2009 ; 95: 1409-1414
31. Edwards CP, Yavari A, Sheppard MN, et al. Anomalous coronary origin: the challenge in preventing exercise-related sudden cardiac death. Br J Sports Med. 2010 ; 44: 895-897
32. Wilson MG, Sharma S, Carre F, et al. Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum. Br J Sports Med. 2012 ; 46: i51 - i58
33. Wilson MG, Basavarajaiah S, Whyte GP, et al. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med. 2008 ; 42: 207-211